Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence (CAMP-2)
Sponsor: Clinical Directors Network
Listed as NCT02566928, this PHASE4 trial focuses on Antibiotic Resistance and Methicillin-Resistant Staphylococcus Aureus and remains ongoing. Sponsored by Clinical Directors Network, it has been updated 8 times since 2015, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE4
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE4
-
Aug 2019 — Jan 2021 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE4
▶ Show 3 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE4
Phase: NA → PHASE4
-
Feb 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Clinical Directors Network
- Patient-Centered Outcomes Research Institute
- Rockefeller University
For direct contact, visit the study record on ClinicalTrials.gov .